Translational Working Group Award
The objective of the Translational Working Group (TWG) awards is to make an impact on the translational goals of the TWGs in research leading to novel approaches in cancer diagnosis, prevention or treatment. The Masonic Cancer Center is especially interested in applications that have potential to translate findings to a clinical trial or clinical application, or in research that takes a clinical observation to the laboratory to study novel cancer mechanisms.
Grant Program Contacts
Application process, requirements, eligibility:
Katie Thomas
Research Development Coordinator
612-624-8679
mccgrant@umn.edu
Applicability of research:
Jill M. Siegfried, PhD
612‐624‐2584
jsiegfri@umn.edu
DNA Repair Inhibition to Kill APOBEC3B-Positive Clear Cell Ovarian Carcinoma
Britt Erickson, University of Minnesota - Medical School - Obstetrics, Gynecology and Women's Health
Effects of Kava on Anxiety and Stress in Cancer Survivors
Naomi Fujioka, University of Minnesota - Medical School - Medicine
Identification and targeting of protein complexes in breast cancer
Julie Ostrander, University of Minnesota - Medical School - Medicine
Justin Drake, PhD, Department of Pharmacology, Medical School
Generation of a screening platform and antigen receptors for therapeutically targeting gastrointestinal malignancies with engineered lymphocytes
Ingunn Stromnes, PhD, Department of Microbiology and Immunology, Medical School
Gastrointestinal TWG
Imaging CD133 in Aggressive Variant Prostate Cancer by Positron Emission Tomography
Aaron LeBeau, PhD, Department of Pharmacology, Medical School
Prostate and Urologic TWG
Targeting RALB signaling to enhance NK immunotherapy for acute myeloid leukemia
Craig Eckfeldt, MD, PhD, Department of Medicine, Medical School
Heme Malignancy TWG
Breast Cancer Translational Working Group Pilot Project - Creation of a Tissue Microarray
Andrew Nelson, MD, PhD, Department of Laboratory Medicine and Pathology, Medical School
Breast Cancer TWG
Skin Health Study Repository for Translational Research: Phase 2
DeAnn Lazovich, MPH, PhD, Epidemiology and Community Health, School of Public Health
Heather Nelson, MPH, PhD, Epidemiology and Community Health, School of Public Health
Cutaneous Oncology TWG
Novel Tissue-Based Biomarkers of Graft-Versus-Host-Disease
Shernan Holtan, MD, Department of Medicine, Medical School
Heme Malignancy TWG
Skin Health Study Repository for Translational Research
DeAnn Lazovich, MPH, PhD, Epidemiology and Community Health, School of Public Health
Heather Nelson, MPH, PhD, Epidemiology and Community Health, School of Public Health
Cutaneous Oncology TWG
SRCBST - Targeting Sarcomas with a New Bispecific Targeted Toxin
Jaime Modiano, VMD, PhD, Veterinary Clinical Sciences, Veterinary Medicine
Sarcoma TWG
Molecular Mechanisms of Leukemia Stem Cell Persistence in AML Relapse
Zohar Sachs, MD, PhD, Department of Medicine, Medical School
David Largaspaeda, PhD, Department of Pediatrics, Medical School
Heme Malignancy TWG
Personalized Mouse Models of Chemotherapy Resistance in Ovarian Cancer
Timothy Starr, PhD, Department of Obstetrics, Gynecology and Women’s Health, Medical School
Gynecological Cancers TWG
Expression Profiling of Breast Cancer with NanoString
Douglas Yee, MD, Department of Medicine, Medical School
Andrew Nelson, Department of Laboratory Medicine and Pathology, Medical School
Breast Cancer TWG